-The Economic Times The government is reviewing the norms for keeping buffer stocks of wheat and rice required at a particular time of the year to feed the public distribution system and welfare schemes. The demand for wheat and rice distributed through welfare schemes is expected to rise with the implementation of the food security law. "The government is looking at the issue and we are discussing it with different departments," KV Thomas,...

-The Hindu     A computerised database of ration card holders and purchases is a safeguard against diversion of PDS supplies but the process can be disruptive for beneficiaries The government has initiated an interesting pilot for the Public Distribution System (PDS) in East Godavari, Andhra Pradesh. When cardholders go to buy their PDS rations, their ration card number and UID (Unique Identification) number are punched into an "e-Point of Sale" (ePOS) machine. If...

-The Indian Express April 1 marked the third anniversary of the passage of the Right of Children for Free and Compulsory Education (RTE). There is little argument that the implementation of the RTE in these three years has been less than satisfactory. Deadlines for the enforcement of input norms - infrastructure, pupil-teacher ratios - have come and gone and potentially game-changing provisions, like 25 per cent reservation for economically weaker sections...

-Frontline The Land Acquisition Bill runs into a roadblock as political parties fail to reach an agreement on the substantive features of the draft Bill or on the amendments proposed. The efforts of the United Progressive Alliance government to broker a consensus on the Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Bill, 2012, which has been pending for over a year, have not paid off not because...

-The Economic Times To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing therapeutics and in delivering affordable healthcare. It is in the light of these facts that one should evaluate the impact of the Indian Supreme Court's ruling in the case involving patent protection for Novartis AG's cancer drug, Glivec. Glivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40...